New drug combo tested for Tough-to-Treat blood cancer
NCT ID NCT07284758
Summary
This study is testing whether a new drug called cemsidomide, when given with a standard steroid (dexamethasone), can help control multiple myeloma that has come back or stopped responding to other treatments. It is for adults who have already tried at least three different types of anti-myeloma therapies. The main goal is to see how many people's cancer shrinks or disappears in response to this combination.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Berenson Cancer Center
RECRUITINGWest Hollywood, California, 90069, United States
Contact
Conditions
Explore the condition pages connected to this study.